CPIC 2026 | Youyi Biotech Special Session: Advanced Stem Cell Culture Processes
Time：
July 22–24, 2026
Place：
shanghai
label：
2026,Industry Conference
Popularity：
0
The 1st China Pharmaceutical Innovation Conference (CPIC), hosted by TONACEA, will be grandly held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai).
Benchmarking the J.P. Morgan Healthcare Conference, CPIC aims to establish a new paradigm of "Chinese Innovation – Global Translation – Shanghai Transaction." As the "premier window" for global capital and enterprises to gain insight into China's innovation ecosystem, and as the "core hub" for Chinese pharmaceutical companies to upgrade, go global, and connect with the world, CPIC is set to become the definitive barometer for annual investment and collaboration in the global health industry. The conference will feature dozens of dedicated sessions covering numerous hot topics and future directions in health industry innovation investment and globalization.
Stem cell therapies are accelerating their transition from the laboratory to the clinic. Scalable, standardized, and cost-effective cell culture processes are the critical bottleneck determining whether this transition can truly succeed. The "Advanced Stem Cell Culture Processes" special session, co-hosted by Youyi Biotech and TONACEA, will focus on core topics such as large-scale stem cell expansion, serum-free culture systems, bioreactor design, and process scale-up. Leading experts from industry, academia, and research will be invited to share practical experiences and cutting-edge breakthroughs. From July 22 to 24 in Shanghai, we look forward to exploring process solutions for stem cell industrialization with you.
Session Theme | Advanced Stem Cell Culture Processes
Organizers | Youyi Biotech, TONACEA
Venue | Hall 4.2, National Exhibition and Convention Center (Shanghai)
The overseas registration link will be available soon. Stay tuned!
Suzhou Youyi Biotechnology Co., Ltd. has established a 1,000 m² R&D laboratory and a 2,000 m² GMP production base in Wujiang District, Suzhou. Utilizing internationally leading jet-milling technology, its dry powder production line can produce up to 500 kg per batch, while its liquid filling line has an annual capacity of 700,000 liters. The company has obtained international quality system certifications including ISO9001, CNAS, and ISO13485, and has completed DMF filings for products such as transient transfection kits, immune cell culture media, and MSC cell culture media. With the vision of stably providing high-quality culture media to customers, the company is committed to helping clients achieve increased efficiency and cost reduction.
Its wholly-owned subsidiary, Shanghai Youyi Biotechnology Co., Ltd., was founded in March 2022 and is a national high-tech enterprise focused on providing differentiated serum-free culture media. Since its establishment, it has successfully completed angel and Series A financing rounds, and has been recognized with numerous honors including Chongben Leading Talent Enterprise, Wujiang District Leading Talent Enterprise, Suzhou Gusu Leading Talent Enterprise, National Technology-Based SME, and National High-Tech Enterprise.
TONACEA is a premier ecosystem platform in China's biomedical innovation sector. With over 20 years of deep engagement in China's innovative drug development, it has grown into a key organizational force driving China's pharmaceutical innovation and serves as a core hub connecting multinational pharmaceutical companies with local innovation.
TONACEA brings together multinational pharmaceutical companies, biotech firms, investment institutions, research institutes, and regulatory experts, establishing a high-end professional network and knowledge-sharing system that covers the entire R&D value chain. Its business encompasses industry summits, technical forums, customized corporate training, media communications, and strategic consulting. With multiple branches across China, TONACEA has built an operational network that extends nationwide. Its official WeChat account and video channel consistently deliver in-depth industry insights, with perspectives frequently cited by investors and media, earning recognition as a trusted authoritative source within the industry.
-
Global Positioning of China's Emerging Pillar Industry
-
Frontiers of Global Biomedical Innovation
-
The Path of Chinese Pharma Companies to Becoming MNCs
-
First-in-Class (FIC) and World-Class Drug Development
-
China's Efficiency in Innovative Drug Development and Continuous Evolution
-
CPIC Achievement Announcements
-
CPIC Honorary Awards
-
CNS Innovative Drug Development Conference
-
Cell Therapy & ATMP Conference
-
In Vivo CAR-T Innovation Forum
-
Gene Therapy & Rare Disease Drug Development Conference
-
Oligonucleotide Drug Innovation Conference
-
mRNA & Vaccine Conference
-
TCE & Novel Antibody Drug Conference
-
Stem Cell & Regenerative Medicine New Technologies Conference
-
Conjugate Drug Innovation Conference
-
New Molecular Entity (NME) Drug R&D Conference
-
Molecular Glue & PROTAC Conference
-
Organoid & Biochip Conference
-
Innovative Radiopharmaceuticals Conference
-
GLP-1 & New Anti-Obesity Drug Conference
-
Biosimilar Development Conference
-
AI & Drug Discovery Conference
-
Trends in New Drug Review and Approval in the EU and US Conference
-
Decree No. 818 and Translational Application of New Biomedical Technologies Conference
-
Decree No. 828 and Accelerated Drug Registration in China Conference
-
China-US Drug Registration Compliance Conference
-
Global Medical Device Registration Regulations Conference
-
Biopharmaceutical IP Strategy and Tactics Conference
-
Legal Forum on Global Market Access for Innovative Drugs
-
Cross-Border Dispute Resolution for Drug Globalization and Licensing Transactions Conference
-
Biologics Segmented Manufacturing Practices Conference
-
Digital Factory and Smart Manufacturing Conference
-
Upstream Supply Chain for Biologics Conference
-
Biologics Separation and Purification Conference
-
Cold Chain Logistics Management Conference
-
Brain-Computer Interface (BCI) Forum
-
Deans of Academic and Medical Institutions Conference
-
Innovative Medical Devices Conference
-
Biomedical New Materials Development Conference
-
Innovation Transformation of Traditional Pharma Companies Conference
-
Biomedical Park Ecosystem Development Conference
-
Research Translation and Early-Stage Project Incubation Conference
-
CRO/CDMO Evolution Conference
-
Accelerating Innovation Through External Partnerships Conference
-
From R&D Story to Profitability Story
-
Biopharmaceutical ESG Development Conference
-
IPO Regulation and Listing Pathways Conference
-
Cross-Border Financing and Dollar Fund Strategy Conference
-
NewCo Evolution and Beyond Conference
-
RWA as a New Financing Tool Conference
-
Banking Support for Innovative Drugs/Devices Conference
-
Biopharmaceutical M&A Conference
-
Project Roadshow Session
-
BD Globalization: Advancement and Ecosystem Restructuring
-
Global Brand Building and Market Promotion for Innovative Drugs
-
Commercialization and Global Market Access for New Drugs Conference
-
Southeast Asia Collaboration Forum
-
China-Singapore Collaboration Forum
-
Hong Kong's Globalization Opportunities Conference
-
China-Europe Collaboration Forum
-
China-Japan Collaboration Forum
-
China-Korea Collaboration Forum
-
Pharma BD Team Building and Global Project Expansion Conference
-
Innovative Talent Strategy and Team Development Conference
-
Scientist Entrepreneurship Workshop
-
Investor Entrepreneurship Conference
-
Institution-Named Special Session
-
Alumni Association Special Session
-
Industry Association Special Session
-
TONACEA Night
-
Networking Reception
-
Themed Luncheon
-
Soul & Aesthetics Art Appreciation
-
10km City Run
-
Golf Tournament
-
Biomedical Park Tours
-
Post-Conference Sightseeing Tour for International Guests
More social events to be announced...
The overseas registration link will be available soon. Stay tuned!
The conference is now accepting submissions for presentations and roadshows. Presentations are 15 minutes, and roadshows are 8 minutes. We welcome your participation!
The conference is now inviting proposals for roundtable dialogue topics and session conveners. Each session will last approximately 40 minutes. We welcome your participation!
The conference features a dedicated 10,000 m² professional exhibition hall for corporate/institutional brand showcasing and networking.
TONACEA
Tel: 010-83634390 / 83634290
Email: txy@cpic-shanghai.com
Registration Inquiries
Zhao Yaxian: 19910727558
Ding Jieyi: 19910274182
Weng Qi: 17751479618
Business Cooperation
Li Jiayuan: 17718589627
Li Zhen: 13522802756
Zhang Mingyue: 15101686528
Ning Yuanyuan: 18710112302
Liu Yang: 18010079080
Yang Yunting: 17365430165
Media Cooperation
Li Chun: 19910611152
Related meetings
Contact us
Address：Room 62, 6th Floor, Building 1, Zone 1, No.186 South 4th Ring West Road , Fengtai District, Beijing
Tel：010-83634390
Address：Address：Room 1704, Building E, Nanotechnology Park, SIP, Suzhou, Jiangsu Province
TONACEA
XIEYI Release
TONACEA Biotech
TONACEA Micro Service
